Clever Leaves (CLVRW) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock CLVRW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Clever Leaves vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Clever Leaves (NASDAQ:CLVRW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership. Does the MarketBeat Community prefer CLVRW or ATNFW? Clever Leaves and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformClever LeavesN/AN/A180 Life SciencesN/AN/A Does the media prefer CLVRW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Clever Leaves. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Clever Leaves. 180 Life Sciences' average media sentiment score of 1.89 beat Clever Leaves' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Clever Leaves Neutral 180 Life Sciences Very Positive Which has better valuation and earnings, CLVRW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClever Leaves$17.42MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is CLVRW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Clever LeavesN/A N/A N/A 180 Life Sciences N/A N/A N/A Summary180 Life Sciences beats Clever Leaves on 2 of the 3 factors compared between the two stocks. Get Clever Leaves News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVRW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLVRW vs. The Competition Export to ExcelMetricClever LeavesDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.15B$5.44B$7.80BDividend YieldN/A2.92%5.43%4.31%P/E RatioN/A4.3122.1418.40Price / SalesN/A499.22389.71101.29Price / CashN/A10.2538.2034.62Price / BookN/A6.376.664.18Net IncomeN/A$20.70B$3.21B$247.71M Clever Leaves Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLVRWClever LeavesN/AN/AN/AN/A$0.00$17.42M0.00560ATNFW180 Life SciencesN/A$0.01-2.5%N/A-20.0%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.02-15.8%N/A-91.1%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.09+10.4%N/AN/A$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$1.30-13.9%N/A-57.2%$0.00$489.68M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/A-70.1%$0.00N/A0.0015BFRIWBiofronteraN/A$0.07+30.5%N/A-23.5%$0.00$37.32M0.0070Gap DownBTMDWbioteN/A$0.03+17.0%N/A-89.1%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.08-16.8%N/A-86.0%$0.00N/A0.008Gap DownCELUWCelularityN/A$0.04+1.9%N/A+56.9%$0.00$48.20M0.00220 Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLVRW) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clever Leaves With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
